PTC (NASDAQ: PTC) will release its fiscal 2026 first quarter and on Wednesday, February 4 th after the stock market closes.

Conference draws participants from more than 60 countries; demand for leadership programs reaches capacity From sold ...

Founded in 1985, the Boston, Massachusetts-based PTC Inc. (PTC) provides software solutions and services globally that aid ...

PTC (NASDAQ: PTC) today announced new artificial intelligence (AI) capabilities for its FlexPLM® retail product lifecycle ...

PTC Therapeutics is keeping its regulatory teams busy. In its third-quarter results, the biotech reported pushback against its plans to seek approval for two molecules based on existing data—and saw ...

Four months after Europe's drug reviewers doubled down and recommended the withdrawal of PTC Therapeutics' Translarna for lack of efficacy, the drug's regulatory odyssey is taking yet another turn.

Shares of PTC Inc. PTC shed 1.18% to $171.52 Friday, on what proved to be an all-around great trading session for the stock ...

PTC Therapeutics, Inc. (NASDAQ:PTCT) on Monday announced results from the Phase 2 PIVOT-HD study of PTC518 (votoplam) in Stage 2 and Stage 3 Huntington’s disease (HD) patients. Huntington’s disease is ...

PTC Therapeutics (PTCT) beats 2025 revenue guidance, details Evrysdi royalties and Sephience growth, and sets 2026 outlook.

PTC's solutions are helping enable a digital revolution in manufacturing, and its long-term growth looks assured. Management's guidance means PTC's growth will be heavily weighted to the second half ...

So if this idea of high risk and high reward doesn't suit, you might be more interested in profitable, growing companies, like PTC (NASDAQ:PTC). While profit isn't the sole metric that should be ...